FDA recall record

Glaxosmithkline Consumer Healthcare Holdings DBA Advil (ibuprofen) Tablets, 200 mg, packaged recall — FDA D-0181-2023

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Class Iclassification
D-0181-2023official record ID
Feb 1, 2023report date

Recall record at a glance

Official recordD-0181-2023
CategoryDrug Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmGlaxosmithkline Consumer Healthcare Holdings DBA Haleon
Report dateFeb 1, 2023
Recall initiation dateDec 6, 2022
Quantity321,246 tablets
LocationWarren, NJ, United States

Official product description

Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940

Why the product was recalled

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Distribution information

Nationwide in the USA.

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.